Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  CYANOTECH CORP    CYAN

Delayed Quote. Delayed  - 09/27 09:31:47 pm
3.6201 USD   -1.36%
09/22 CYANOTECH : reg; Corporation Earns Non-GMO Project Verification for ..
08/31 CYANOTECH : BioAstin® Hawaiian Astaxanthin® Products First to Receiv..
08/15 CYANOTECH : Reports Financial Results for the First Quarter of Fisca..
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsSector news 

CYANOTECH : Michael A. Davis Named Chairman of the Board of Directors of Cyanotech

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2011 | 02:10pm CEST

Michael A. Davis has been elected as Chairman of the Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces Gregg Robertson, who resigned in late 2010.

Mr. Davis was Vice-Chairman of the Board and has been a Director of Cyanotech since March 2003.

"Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years," said Brent Bailey, President and CEO. "We look forward to his continuing support and leadership as Chairman of the Board."

Mr. Davis, a private Investor and major shareholder of Cyanotech since 1994, is also President of Skywords Family Foundation and a Director of Canobie Films, Inc.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®--all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.

Cyanotech Corporation
Bruce Russell, 310-559-4955 x101


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CYANOTECH CORP
09/22 CYANOTECH : reg; Corporation Earns Non-GMO Project Verification for BULK SCE Bio..
09/09 CYANOTECH CORP : Other Events (form 8-K)
09/01 CYANOTECH CORP : Entry into a Material Definitive Agreement, Creation of a Direc..
08/31 CYANOTECH : BioAstin® Hawaiian Astaxanthin® Products First to Receive NAXA Verif..
08/29 CYANOTECH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
08/15 CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
08/15 CYANOTECH : Reports Financial Results for the First Quarter of Fiscal Year 2017
06/24 CYANOTECH : accounting fix blamed for its loss
06/23 CYANOTECH : Management's Discussion and Analysis of Financial Condition and Resu..
06/23 CYANOTECH : Reports Financial Results for the Fourth Quarter and Fiscal Year 201..
More news
Sector news : Biopharmaceuticals
12:00p Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
09/26DJPFIZER : Throws Out Plan to Split Into Two Companies -- 2nd Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
08/15 Cyanotech reports FQ1 results
06/23 Cyanotech revenues off 4% in FQ4
06/23 Cyanotech reports FY16 results
04/06 INSIDERINSIGHTS.COM DAILY ROUND UP 4 : Cyan, wlh, smlp, vtvt
03/20 INSIDERINSIGHTS.COM DAILY ROUND UP 3 : Tsro, cvgi, cyan, cara
Advertisement
Chart CYANOTECH CORP
Duration : Period :
CYANOTECH CORP Technical Analysis Chart | CYAN | US2324373016 | 4-Traders
Full-screen chart
Managers
NameTitle
Gerald R. Cysewski President, Chief Executive Officer & Director
Michael A. Davis Chairman
Gerard J. Watts Chief Operating Officer
Jolé Eileen Deal CFO, Secretary, Treasurer & VP-Administration
Walter B. Menzel Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYANOTECH CORP-31.05%0
CSL LIMITED0.75%36 887
ALEXION PHARMACEUTICAL..-33.96%27 921
GRIFOLS SA-9.50%13 373
3SBIO INC-21.30%2 785
JIANGXI BOYA BIO-PHARM..--.--%2 526
More Results